NSPR
InspireMD, Inc.
NASDAQ · ILHealthcareMedical - Devices
$0.70+0.33%
Price as of Jul 20, 2026
NSPR growth
InspireMD, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +54.4%
- EBITDA
- +0.9%
- EBIT
- -38.8%
- EPS
- +28.3%
- Free cash flow
- -47.8%
- Operating cash flow
- -51.0%
Forward estimates
- Revenue
- +93.9%
- EBITDA
- +42.6%
- EPS
- -5.4%
Three-year CAGR
- Revenue
- +20.2%
- EBITDA
- -52.4%
- EBIT
- -46.6%
- Net income
- -52.4%
- EPS
- +0.0%
- Free cash flow
- -58.0%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.